# Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities

> **NCT02406274** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 249 (actual)

## Conditions studied

- Breast Abnormalities

## Interventions

- **OTHER:** Contrast Enhanced Spectral Mammography (CESM)

## Key facts

- **NCT ID:** NCT02406274
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2024-06-27
- **Final completion:** 2024-06-27
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2024-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02406274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02406274, "Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02406274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*